Income Statement genOway

Stocks

ALGEN

FR0004053510

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:55:00 2026-09-25 EDT			5-day change	1st Jan Change
2.360 ^EUR	-1.67%		-4.84%	-12.92%

09-23	GenOway teams up with Taconic Biosciences to accelerate in the United States
09-23	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026	CI

bfb.ohiVfV5JBpC1pWQE4T1pHdphKNZFce22hQtzAucUd3A.8FL0Tid7bafk8Sh8lV4tTYMmTIk_J4Pg1UpLRY5LBDr4euxKFHpjvc_EAw

Published financial data: GENOWAY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	15.79M	18.36M	20.05M	22.06M	20.96M
Other Revenues, Total	3.81M	2.73M	4.97M	3.78M	5.07M
Total Revenues	19.59M	21.09M	25.02M	25.84M	26.03M
Cost of Goods Sold, Total	9.39M	9.3M	10.67M	12.81M	13.27M
Gross Profit	10.2M	11.79M	14.35M	13.04M	12.76M
Selling General & Admin Expenses, Total	8.22M	8.04M	9.2M	10.24M	10.37M
Depreciation & Amortization - (IS)	1.92M	2.52M	4.25M	2.59M	3.41M
Other Operating Expenses	848K	748K	-674K	-1.1M	-2.29M
Other Operating Expenses, Total	10.99M	11.3M	12.78M	11.73M	11.49M
Operating Income	-789K	489K	1.57M	1.3M	1.27M
Interest Expense, Total	-112K	-122K	-109K	-147K	-308K
Interest And Investment Income	-	3.49K	16.12K	63.3K	26.37K
Net Interest Expenses	-112K	-119K	-92.95K	-83.21K	-281K
Currency Exchange Gains (Loss)	91.23K	142K	90.11K	50.8K	23.27K
Other Non Operating Income (Expenses)	89.36K	-163K	14.14K	315K	-
EBT, Excl. Unusual Items	-721K	349K	1.58M	1.59M	1.02M
Gain (Loss) On Sale Of Investments	-	-37.5K	-31.71K	-86.13K	86.13K
Gain (Loss) On Sale Of Assets	-	-	-	-	-184K
Other Unusual Items	369K	447K	2.86K	306K	-
EBT, Incl. Unusual Items	-352K	759K	1.55M	1.81M	918K
Income Tax Expense	-29.34K	-18.81K	-20K	-23.14K	-10.16K
Earnings From Continuing Operations	-323K	778K	1.57M	1.83M	928K
Net Income to Company	-323K	778K	1.57M	1.83M	928K
Net Income - (IS)	-323K	778K	1.57M	1.83M	928K
Net Income to Common Incl Extra Items	-323K	778K	1.57M	1.83M	928K
Net Income to Common Excl. Extra Items	-323K	778K	1.57M	1.83M	928K
Per Share Items
Net EPS - Basic	-	-	-	-	-
Basic EPS - Continuing Operations	-	-	-	-	-
Basic Weighted Average Shares Outstanding	-	-	-	-	-
Net EPS - Diluted	-	-	-	-	-
Diluted EPS - Continuing Operations	-	-	-	-	-
Diluted Weighted Average Shares Outstanding	-	-	-	-	-
Normalized Basic EPS	-	-	-	-	-
Normalized Diluted EPS	-	-	-	-	-
Supplemental Items
EBITDA	432K	3.01M	5.81M	3.89M	4.43M
EBITA	-789K	489K	1.57M	1.3M	3.03M
EBIT	-789K	489K	1.57M	1.3M	1.27M
Total Revenues (As Reported)	19.8M	21.4M	26.59M	27.66M	28.56M
Effective Tax Rate - (Ratio)	8.34	-2.48	-1.29	-1.28	-1.11
Normalized Net Income	-450K	218K	985K	992K	635K

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	5.61M	4.88M	4.26M	4.95M	549K
Short Term Investments	-	-	-	-	6.5M
Total Cash And Short Term Investments	5.61M	4.88M	4.26M	4.95M	7.05M
Accounts Receivable, Total	6.36M	7.84M	5.14M	6.36M	8.89M
Other Receivables	6.14M	5.75M	7.12M	4.8M	5.6M
Total Receivables	12.5M	13.59M	12.26M	11.16M	14.5M
Inventory	979K	1.19M	983K	1.09M	994K
Prepaid Expenses	248K	170K	231K	248K	353K
Total Current Assets	19.33M	19.82M	17.73M	17.45M	22.9M
Gross Property Plant And Equipment	11.34M	11.87M	12.02M	12.65M	21M
Accumulated Depreciation	-4.17M	-5.21M	-6.14M	-7.09M	-8.49M
Net Property Plant And Equipment	7.17M	6.67M	5.88M	5.56M	12.51M
Long-term Investments	-	-	1.69M	1.7M	1.7M
Goodwill	197K	197K	197K	197K	197K
Other Intangibles, Total	5.25M	5.33M	5.46M	5.58M	6.36M
Loans Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	716K	904K	891K	1.31M	1.69M
Total Assets	32.66M	32.92M	31.84M	31.8M	45.35M
Liabilities
Accounts Payable, Total	2.22M	2.62M	2.58M	2.89M	2.81M
Accrued Expenses, Total	1.87M	2.04M	2.32M	2.6M	2.12M
Short-term Borrowings	5.29K	7.22K	9.81K	3.81K	7.52K
Current Portion of Long-Term Debt	1.83M	1.84M	1.7M	1.43M	1.29M
Current Income Taxes Payable	8.24K	33.63K	23.44K	8.53K	3.13K
Unearned Revenue Current, Total	1.82M	2.23M	1.69M	1.6M	1.06M
Other Current Liabilities	531K	65.78K	64.59K	56.34K	6.21K
Total Current Liabilities	8.28M	8.83M	8.39M	8.6M	7.29M
Long-Term Debt	8.99M	7.19M	5.52M	4.14M	12.48M
Unearned Revenue Non Current	240K	136K	215K	197K	332K
Other Non Current Liabilities	425K	598K	331K	294K	281K
Total Liabilities	17.94M	16.76M	14.46M	13.23M	20.38M
Common Stock, Total	5.45M	5.45M	5.56M	5.69M	7.48M
Additional Paid In Capital	9.22M	9.22M	9.14M	9.04M	13.9M
Retained Earnings	-1.51M	-730K	838K	2.67M	3.6M
Comprehensive Income and Other	1.56M	2.23M	1.84M	1.17M	-
Total Common Equity	14.72M	16.17M	17.38M	18.57M	24.97M
Total Equity	14.72M	16.17M	17.38M	18.57M	24.97M
Total Liabilities And Equity	32.66M	32.92M	31.84M	31.8M	45.35M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	-	-	-
ECS Total Common Shares Outstanding	-	-	-	-	-
Book Value / Share	-	-	-	-	-
Tangible Book Value	9.27M	10.64M	11.73M	12.8M	18.42M
Tangible Book Value Per Share	-	-	-	-	-
Total Debt	10.83M	9.04M	7.23M	5.58M	13.77M
Net Debt	5.22M	4.16M	2.97M	623K	6.72M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	449K
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	194K	254K	396K	485K	457K
Inventories - Work In Process, Total	785K	931K	587K	605K	537K
Land - (BS)	251K	251K	251K	251K	251K
Buildings, Total	3.51M	3.51M	3.51M	3.51M	8.44M
Machinery, Total	6.97M	7.51M	7.66M	8.29M	11.7M
Full Time Employees	118	124	133	141	157
Accumulated Allowance for Doubtful Accounts (Supple)	184K	347K	1.81M	1.8M	1.92M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	-	-	-	-	928K
Depreciation & Amortization - CF	-	-	-	-	1.4M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	1.75M
Depreciation & Amortization, Total	-	-	-	-	3.15M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	43.46K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-	-	-	-	-714K
Change In Accounts Receivable	-	-	-	-	-2.52M
Change In Inventories	-	-	-	-	96.16K
Change In Accounts Payable	-	-	-	-	-87.36K
Change in Unearned Revenues	-	-	-	-	-586K
Change In Income Taxes	-	-	-	-	-480K
Change in Other Net Operating Assets	-	-	-	-	-1.26M
Cash from Operations	-	-	-	-	-1.43M
Capital Expenditure	-	-	-	-	-8.35M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-2.58M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-394K
Cash from Investing	-	-	-	-	-11.32M
Long-Term Debt Issued, Total	-	-	-	-	9.62M
Total Debt Issued	-	-	-	-	9.62M
Long-Term Debt Repaid, Total	-	-	-	-	-1.43M
Total Debt Repaid	-	-	-	-	-1.43M
Issuance of Common Stock	-	-	-	-	6.65M
Cash from Financing	-	-	-	-	14.84M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-	-	-	-	2.1M
Supplemental Items
Levered Free Cash Flow	-	-	-	-	-11.63M
Unlevered Free Cash Flow	-	-	-	-	-11.44M
Change In Net Working Capital	2.67M	681K	-1.17M	-1.45M	4.51M
Net Debt Issued / Repaid	-	-	-	-	8.2M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	-1.64	0.93	3.02	2.56	2.06
Return on Total Capital	-2.18	1.2	3.93	3.34	2.53
Return On Equity %	-2.72	5.04	9.34	10.18	4.26
Return on Common Equity	-2.72	5.04	9.34	10.18	4.26
Margin Analysis
Gross Profit Margin %	52.08	55.92	57.34	50.45	49.02
SG&A Margin	41.96	38.12	36.79	39.63	39.83
EBITDA Margin %	2.2	14.25	23.24	15.07	17.01
EBITA Margin %	-4.03	2.32	6.26	5.05	11.63
EBIT Margin %	-4.03	2.32	6.26	5.05	4.89
Income From Continuing Operations Margin %	-1.65	3.69	6.27	7.08	3.56
Net Income Margin %	-1.65	3.69	6.27	7.08	3.56
Net Avail. For Common Margin %	-1.65	3.69	6.27	7.08	3.56
Normalized Net Income Margin	-2.3	1.04	3.94	3.84	2.44
Levered Free Cash Flow Margin	-	-	-	-	-44.69
Unlevered Free Cash Flow Margin	-	-	-	-	-43.95
Asset Turnover
Asset Turnover	0.65	0.64	0.77	0.81	0.67
Fixed Assets Turnover	2.61	3.05	3.99	4.52	2.88
Receivables Turnover (Average Receivables)	2.7	2.59	3.09	3.84	2.75
Inventory Turnover (Average Inventory)	8.77	8.59	9.85	12.35	12.73
Short Term Liquidity
Current Ratio	2.33	2.24	2.11	2.03	3.14
Quick Ratio	2.19	2.09	1.97	1.87	2.96
Operating Cash Flow to Current Liabilities	-	-	-	-	-0.2
Days Sales Outstanding (Average Receivables)	135.4	141.11	118.15	95.42	132.87
Days Outstanding Inventory (Average Inventory)	41.62	42.49	37.07	29.63	28.66
Average Days Payable Outstanding	89.3	92.79	90.57	77.59	78.97
Cash Conversion Cycle (Average Days)	87.72	90.81	64.64	47.45	82.56
Long Term Solvency
Total Debt/Equity	73.54	55.9	41.61	30.02	55.14
Total Debt / Total Capital	42.38	35.85	29.38	23.09	35.54
LT Debt/Equity	61.11	44.48	31.75	22.28	49.96
Long-Term Debt / Total Capital	35.21	28.53	22.42	17.14	32.21
Total Liabilities / Total Assets	54.93	50.9	45.41	41.59	44.94
EBIT / Interest Expense	-7.05	4	14.35	8.9	4.14
EBITDA / Interest Expense	3.86	24.63	53.31	26.58	14.4
(EBITDA - Capex) / Interest Expense	3.86	24.63	53.31	26.58	-12.76
Total Debt / EBITDA	25.07	3.01	1.24	1.43	3.11
Net Debt / EBITDA	12.09	1.38	0.51	0.16	1.52
Total Debt / (EBITDA - Capex)	25.07	3.01	1.24	1.43	-3.51
Net Debt / (EBITDA - Capex)	12.09	1.38	0.51	0.16	-1.71
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.29	7.65	26.47	3.29	0.72
Gross Profit, 1 Yr. Growth %	13.91	15.56	36.81	-9.11	-2.14
EBITDA, 1 Yr. Growth %	-48.84	596.24	93.43	-33.03	2.69
EBITA, 1 Yr. Growth %	109.32	-161.9	220.31	-16.65	125.6
EBIT, 1 Yr. Growth %	109.32	-161.9	220.31	-16.65	-5.07
Earnings From Cont. Operations, 1 Yr. Growth %	-53.06	-341.09	101.55	16.79	-49.32
Net Income, 1 Yr. Growth %	-53.06	-341.09	101.55	16.79	-49.32
Normalized Net Income, 1 Yr. Growth %	72.63	-148.48	351.22	0.69	-44.66
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	-
Accounts Receivable, 1 Yr. Growth %	18.76	23.27	-34.43	23.79	39.81
Inventory, 1 Yr. Growth %	-15.7	21.04	-17.09	10.94	-8.82
Net Property, Plant and Equip., 1 Yr. Growth %	-8.95	-7	-11.81	-5.42	124.98
Total Assets, 1 Yr. Growth %	18.47	0.81	-3.28	-0.13	42.62
Tangible Book Value, 1 Yr. Growth %	100.96	14.69	10.26	9.14	43.91
Common Equity, 1 Yr. Growth %	63.6	9.83	7.53	6.86	34.45
Cash From Operations, 1 Yr. Growth %	-	-	-	-	-126.49
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	1.23K
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-	-	-519.16
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-	-	-499.06
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.14	13.7	17.83	13.84	1.16
Gross Profit, 2 Yr. CAGR %	11.84	14.57	28.91	10.68	-7.04
EBITDA, 2 Yr. CAGR %	-15.53	84.68	233.44	11.21	-19.36
EBITA, 2 Yr. CAGR %	17.15	19.94	49.73	43.78	12
EBIT, 2 Yr. CAGR %	17.15	19.94	49.73	43.78	-27.35
Earnings From Cont. Operations, 2 Yr. CAGR %	-44.21	6.38	120.44	53.42	-23.07
Net Income, 2 Yr. CAGR %	-44.21	6.38	120.44	53.42	-23.07
Normalized Net Income, 2 Yr. CAGR %	-6.21	-8.52	47.9	125.61	-35.6
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 2 Yr. CAGR %	25.38	20.99	-10.1	-9.91	31.56
Inventory, 2 Yr. CAGR %	20.32	1.02	0.18	-4.1	0.57
Net Property, Plant and Equip., 2 Yr. CAGR %	10.93	-7.98	-9.44	-8.67	45.88
Total Assets, 2 Yr. CAGR %	30.58	9.28	-1.26	-1.72	19.35
Tangible Book Value, 2 Yr. CAGR %	58.26	51.82	12.45	9.7	25.32
Common Equity, 2 Yr. CAGR %	46.67	34.04	8.67	7.19	19.86
Cash From Operations, 2 Yr. CAGR %	-	-	-	-	-
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.43	13.89	15.32	12.77	9.29
Gross Profit, 3 Yr. CAGR %	5.83	13.07	16.88	14.74	6.23
EBITDA, 3 Yr. CAGR %	-32.86	70.63	87.55	95.27	12.03
EBITA, 3 Yr. CAGR %	10.83	-5.29	66.4	23.17	68.64
EBIT, 3 Yr. CAGR %	10.83	-5.29	66.4	23.17	26.38
Earnings From Cont. Operations, 3 Yr. CAGR %	-17.36	-9.13	31.63	78.37	6.05
Net Income, 3 Yr. CAGR %	-17.36	-9.13	31.63	78.37	6.05
Normalized Net Income, 3 Yr. CAGR %	20.65	-24.73	55.72	30.11	48.23
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 3 Yr. CAGR %	32.17	24.68	-1.36	0.02	4.31
Inventory, 3 Yr. CAGR %	21.61	20.56	-5.42	3.64	-5.7
Net Property, Plant and Equip., 3 Yr. CAGR %	4.66	4.6	-9.28	-8.12	23.35
Total Assets, 3 Yr. CAGR %	18.38	19.79	4.92	-0.88	11.27
Tangible Book Value, 3 Yr. CAGR %	21.52	42.15	36.46	11.34	20.09
Common Equity, 3 Yr. CAGR %	23.1	33.19	24.55	8.06	15.6
Cash From Operations, 3 Yr. CAGR %	-	-	-	-	-
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.17	9.89	10.84	12.6	9.8
Gross Profit, 5 Yr. CAGR %	9.16	9.83	10.75	9.83	7.27
EBITDA, 5 Yr. CAGR %	-15.96	22.45	32.44	45.11	38.1
EBITA, 5 Yr. CAGR %	-2.02	-8.3	21.97	17.8	54.87
EBIT, 5 Yr. CAGR %	2.67	-8.3	21.97	17.8	30.25
Earnings From Cont. Operations, 5 Yr. CAGR %	-11.14	-16.63	22.35	12.05	6.18
Net Income, 5 Yr. CAGR %	-11.14	-16.63	22.35	12.05	6.18
Normalized Net Income, 5 Yr. CAGR %	0.18	-10.25	30.89	14.14	19.46
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 5 Yr. CAGR %	13.5	25.03	13.29	9.48	10.68
Inventory, 5 Yr. CAGR %	5.82	20.37	12.54	10.02	-3.07
Net Property, Plant and Equip., 5 Yr. CAGR %	71.53	3.44	-1.23	-0.93	9.7
Total Assets, 5 Yr. CAGR %	22.79	13.91	10.09	10.67	10.47
Tangible Book Value, 5 Yr. CAGR %	15.58	10.07	17.81	28.16	31.89
Common Equity, 5 Yr. CAGR %	22.85	17.59	17.11	22.11	22.65
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-